One‐third of epilepsy patients remain treatment‐resistant, underscoring the need for novel anti‐seizure medications (ASMs) and reliable biomarkers of central target engagement. Cortical hyperexcitability is a hallmark of epilepsy, making excitability a valuable pharmacodynamic biomarker for early‐phase drug development supporting go/no‐go decision ...
Catherine M. E. de Cuba +7 more
wiley +1 more source
Pediatric Investigation Plans for seizure and epilepsy treatments: An analysis since the implementation of the European Pediatric Regulation in 2006. [PDF]
Agostini V, Auvin S.
europepmc +1 more source
Phenotypic heterogeneity in familial epilepsies is influenced by polygenic risk for generalized and focal epilepsies. [PDF]
Ellis CA +5 more
europepmc +1 more source
Status Epilepsy Syndromes Made Easy: Pediatric Perspectives. [PDF]
Hon KLE +3 more
europepmc +1 more source
Epilepsies and Mirror Movements: An Underrecognized Association? [PDF]
Nardone R, Trinka E.
europepmc +1 more source
The potential of laminar functional MRI in refining the understanding of epilepsy in humans. [PDF]
Aitken F +3 more
europepmc +1 more source
Metabolic pathways and genes involved in treatable and non-treatable metabolic epilepsies. A comprehensive review and metabolic pathway analysis. [PDF]
Sesse A +5 more
europepmc +1 more source
Related searches:
Mechanism of gating and partial agonist action in the glycine receptor
Cell, 2021Hongtao Zhu +2 more
exaly
Factors governing partial coalescence in oil-in-water emulsions
Advances in Colloid and Interface Science, 2010Koen Dewettinck
exaly

